Additionally, the authors proposed that cachexia-associated systemic inflammation, as indicated by increased CRP levels, may decrease CYP3A4 levels by downregulating its expression, possibly leading to increased plasma fentanyl concentrations [27]. This evidence concerns the gene CYP3A4 and Cachexia.